Xtant Medical Holdings (XTNT) EBITDA Margin Growth (3y) (2013 - 2025)
Xtant Medical Holdings (XTNT) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -343.00 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 17.00 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 78.00 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 487.00 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -283.00 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1,505.00 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -763.00 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -184.00 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Xtant Medical Holdings | 5.69 Mn | -11.63 Mn | 17.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2,078.00 |
| Jun 30, 2025 | 2,157.00 |
| Mar 31, 2025 | 1,737.00 |
| Dec 31, 2024 | 761.00 |
| Sep 30, 2024 | -303.00 |
| Jun 30, 2024 | -656.00 |
| Mar 31, 2024 | -1,241.00 |
| Dec 31, 2023 | -1,525.00 |
| Sep 30, 2023 | -1,895.00 |
| Jun 30, 2023 | -320.00 |
| Mar 31, 2023 | 47.00 |
| Dec 31, 2022 | -942.00 |
| Sep 30, 2022 | -865.00 |
| Jun 30, 2022 | -482.00 |
| Mar 31, 2022 | -1,015.00 |
| Dec 31, 2021 | 28,608.00 |
| Sep 30, 2021 | -218.00 |
| Jun 30, 2021 | 884.00 |
| Mar 31, 2021 | 925.00 |
| Dec 31, 2020 | 8,987.00 |